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Epigenetic modifications on chromatin play important roles in regulating gene expression. Although chromatin states are
often governed by multilayered structure, how individual pathways contribute to gene expression remains poorly under-
stood. For example, DNA methylation is known to regulate transcription factor binding but also to recruit methyl-CpG
binding proteins that affect chromatin structure through the activity of histone deacetylase complexes (HDACs). Both of
these mechanisms can potentially affect gene expression, but the importance of each, and whether these activities are inte-
grated to achieve appropriate gene regulation, remains largely unknown. To address this important question, we measured
gene expression, chromatin accessibility, and transcription factor occupancy in wild-type or DNA methylation-deficient
mouse embryonic stem cells following HDAC inhibition. We observe widespread increases in chromatin accessibility at ret-
rotransposons when HDACs are inhibited, and this is magnified when cells also lack DNA methylation. A subset of these
elements has elevated binding of the YY1 and GABPA transcription factors and increased expression. The pronounced ad-
ditive effect of HDAC inhibition in DNA methylation–deficient cells demonstrates that DNA methylation and histone
deacetylation act largely independently to suppress transcription factor binding and gene expression.
[Supplemental material is available for this article.]
Themost abundantDNAmodification inmammals is 5-methylcy-
tosine (5mC) which is found predominantly within CpG dinucle-
otides (Lister et al. 2009; Stadler et al. 2011). DNA methylation is
deposited and maintained through the concerted activity of three
essential DNA methyltransferases (DNMT1, DNMT3A, DNMT3B)
(Goll and Bestor 2005) and plays important roles in transcriptional
repression. For example, DNA methylation is known to regulate
imprinted genes (Kaneda et al. 2004), some tissue-restricted genes
(De Smet et al. 1999; Maatouk et al. 2006; Borgel et al. 2010), evo-
lutionarily young retrotransposons (Davis et al. 1989; Walsh et al.
1998; Castro-Diaz et al. 2014), genes on the inactive X
Chromosome (Beard et al. 1995; Hansen et al. 1996), and certain
tumor suppressor genes in cancer cells (Toyota et al. 1999; Rhee
et al. 2002; Robert et al. 2003).
Although 60%–80% of CpGs in the genome are methylated,
DNA methylation is absent or reduced in regions bound by tran-
scription factors such as in CpG islands, gene promoters, and distal
regulatory elements (Stadler et al. 2011; Hon et al. 2013; Ziller et al.
2013). This observation led to the proposal that DNAmethylation
may limit transcription factor occupancy. In support of this mod-
el, in vitro experiments have revealed that 5mC can affect the af-
finity of most DNA-binding proteins that contain CpG
dinucleotides in their binding motif (Hu et al. 2013; Spruijt et al.
2013; Kribelbauer et al. 2017; Yin et al. 2017). Furthermore, certain
transcription factors (TFs), including NRF1 and CTCF, have been
shown to have altered binding profiles in cells where DNA meth-
ylation is reduced or absent (Domcke et al. 2015; Maurano et al.
2015; Yin et al. 2017).
In addition to directly altering the binding of transcription
factors, methylated CpG is recognized by methyl binding
domain-containing (MBD) and zinc-finger methyl-cytosine bind-
ing proteins (Hendrich and Bird 1998; Lopes et al. 2008; Quenne-
ville et al. 2011). MBD proteins interact with histone deacetylase
(HDAC) enzymes and promote the formation of transcriptionally
repressive chromatin environments (Nan et al. 1998; Zhang et al.
1999; Kokura et al. 2001; Yoon et al. 2003) via the removal of acetyl
groups from lysine residues in histones.
Despite the active recruitment of HDACs to methylated
CpGs, the extent towhichDNAmethylation relies onHDACactiv-
ity to affect gene expression is still poorly understood. HDAC inhi-
bition, or disruption of the interaction betweenMBD proteins and
the HDAC-containing complexes, has been shown to alleviate
transcriptional silencing mediated by DNAmethylation in report-
er gene assays (Jones et al. 1998; Nan et al. 1998; Ng et al. 1999;
Lyst et al. 2013). Nevertheless, at other endogenous genes, inhib-
iting HDACs did not recapitulate the effects on gene expression
that manifest when DNA methylation is removed (Cameron
et al. 1999; Coffee et al. 1999; Brunmeir et al. 2010; Reichmann
et al. 2012). Therefore, although it is clear that DNA methylation
is capable of altering TF-DNA interactions and recruiting HDACs,
how these distinct mechanisms contribute to DNA methylation-
dependent repression at the genome scale remains unknown.
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Failure to inactivate transcription and mobility of retrotrans-
posons has been linked to genome instability in cancer (Carreira
et al. 2014; Tubio et al. 2014; Scott and Devine 2017; Schauer
et al. 2018) and the manifestation of neurological diseases
(Coufal et al. 2011). DNAmethylation is an important contributor
to silencing of retrotransposons, where it acts in concert with his-
tone deacetylation and histone (H3K9) methylation (Bourc’his
and Bestor 2004; Karimi et al. 2011; Rowe et al. 2013; Sharif
et al. 2016).Whether chromatinmechanisms are redundant or col-
laborative while acting on different classes of retrotransposons is
incompletely understood.
In this study, we aimed to determine individual and collabo-
rative roles of DNA methylation and HDAC activity. To this pur-
pose, we disrupted both processes, one at a time or in
combination, in mouse embryonic stem cells and measured the
impact on chromatin accessibility, transcription factor occupancy,
and gene regulation.
Results
Disruption of HDAC activity and DNA methylation in mouse
embryonic stem cells
To determine the contribution ofDNAmethylation and the activity
of HDAC enzymes on transcriptional regulation, we treated wild-
type (J1) or Dnmt3a/Dnmt3b/Dnmt1 triple knockout (DNMT.TKO)
mouse embryonic stem cells (Tsumura et al. 2006) with the HDAC
inhibitor trichostatin A (TSA) (Fig. 1A). The chosen dose of TSA
had minimal effects on the morphology or cell cycle of mESCs
(Supplemental Fig. S1A) but yielded a robust increase in global his-
tone acetylation as detected by immunoblotting (Fig. 1B). There
were no significant changes in global 5mC levels between TSA-
and DMSO (solvent)-treated cells (Supplemental Fig. S1B).
To examine histone acetylation in more detail, we performed
native calibrated ChIP-seq for acetylated histone H3 (H3ac). TSA
treatment led to a global increase in H3ac in wild-type and
DNMT.TKO cells both at previously hyperacetylated sites (ChIP-
seq peaks) and the remaining genomic space (Fig. 1C–E; Supple-
mental Fig. S1C). The increase in histone acetylation at repetitive
regions and unannotated genomic loci following HDAC inhibi-
tion was greater in DNMT.TKO compared to wild-type cells (Fig.
1E). This observation coincides with high DNAmethylation levels
in the aforementioned regions in WT cells, whereas hyperacety-
lated sites contain low median DNA methylation (Supplemental
Fig. S1D). This additive effect of DNA methylation loss and
HDAC inhibition on histone acetylation in these regions could
be explained by enhanced recruitment of histone acetyltransfer-
ases (HATs), potentiated by DNA-binding proteins with specificity
to unmodified CpGs (e.g., CxxC-domain proteins). Alternatively,
the lack of DNA methylation may disrupt the recruitment of
HDACs by MBD-domain proteins, resulting in a lower capacity
for compensatory mechanisms to deacetylate histones or prevent
histone acetylation.
In summary, HDAC inhibition using TSA induces histone
acetylation broadly across the genome with no detectable change
in DNA methylation, enabling us to evaluate the extent and the






Figure 1. Disruption of HDAC activity and DNA methylation in mouse embryonic stem cells. (A) Schematic of the experimental approach used in this
study. (B) Immunoblot analysis of global histone H3 and H4 acetylation levels after 36-h TSA treatment in mESCs. Samples were derived from three bio-
logical replicate experiments. (C) Representative snapshot of genomic region showing H3ac ChIP-seq read coverage calibrated to the spike-in galGal4 ge-
nome. (D) Metaplot showing the average calibrated H3ac ChIP-seq signal from DMSO- or TSA-treated wild-type and DNMT.TKO cells in 10-kb regions
surrounding the center of ChIP-seq peaks (n=28608). (E) Distribution of H3ac ChIP-seq reads within genomic intervals separated into three mutually ex-
clusive categories. For every sample, the number of mm10 reads overlapping each category was divided by the total number of reads mapping to the
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DNA methylation and HDAC activity have distinct contributions
to the chromatin accessibility landscape
To compare the impact of DNA methylation and histone acetyla-
tion on chromatin function, we profiled chromatin accessibility
in wild-type and DNMT.TKO cells in the absence or presence of
TSA using ATAC-seq (Fig. 1A).
Employing this data, we first defined a set of 83,395 transpo-
sase hypersensitive sites (THSs) that were called as significantly ac-
cessible in at least one experimental condition. Sample-to-sample
correlations and a principle component analysis both clustered bi-
ological replicate samples together, demonstrating that treatment
and genotype induced reproducible changes in accessibility
(Supplemental Fig. S2A–C). We identified THSs that display differ-
ential accessibility by examining the effect of DNA methylation
loss, or that of HDAC inhibition in either wild-type or DNAmeth-
ylation-deficient cells (Fig. 2A). In all comparisons, regions that
gained accessibility had a lower CpG and GC content than un-
changed ones, which was related to the reduced presence of differ-
ential THSs at promoters (Supplemental Fig. S2D–G).
We first focused on comparing DNMT.TKO to WT DMSO-
treated cells in order to characterize the chromatin accessibility
changes that occur following the loss of 5mC. We identified
6427 THS regions that significantly gained accessibility and 7135
that significantly lost accessibility in the absence of DNA methyl-
ation (Fig. 2A, left). Significant increases in ATAC-seq signal
occurred preferentially at loci that showed low accessibility in
wild-type cells, whereas significant decreases were more broadly
detected at regions with intermediate levels of wild-type accessibil-
ity, a finding that was consistent when using more stringent FDR
thresholds for calling significant differences (Supplemental Fig.
S2H). Differential THS regions account for ∼16% of all sites that
were detected as being accessible in wild-type or DNMT.TKO
mES cells when using a FDR threshold of 0.01, demonstrating
thatDNAmethylationhas an important role inmaintaining acces-
sibility patterns. However, complete loss of DNA methylation in
mouse ES cells does not produce widespread alterations, in agree-
ment with similar results obtained using DNase-seq (Domcke
et al. 2015).
To assess the fraction of differential accessibility events that
occur as a direct consequence of a loss in DNA methylation, we
made use of public whole-genome bisulfite sequencing (WGBS)
data generated from E14 mESCs grown under the same growth
conditions (Habibi et al. 2013). Similar to previous observations
(Domcke et al. 2015), we found that gains in accessibility in
DNMT.TKO cells frequently occur at regions that are methylated
in WT cells (Supplemental Fig. S2I, top right quadrant). Specifi-
cally, 56% of DNMT.TKO loci that significantly gain in accessibil-
ity have a mean methylation value above 60% in WT cells
(Supplemental Fig. S2I). These represent loci at which DNAmeth-
ylation is likely to play a role in restraining the formation of a Tn5
accessible state, potentially through interference with transcrip-
tion factor binding. On the other hand, the relationship between
accessibility reduction in DNMT.TKO cells and DNA methylation
is less straightforward (Supplemental Fig. S2I). Only 2.8% of the re-
gions displaying significantly reduced accessibility in DNMT.TKO
cells have high levels of methylation in wild-type cells (≥60%
methylation), making it more difficult to attribute these differenc-
es in chromatin accessibility to changes in methylation.
Screening a collection of 264 known vertebrate transcription
factormotifs (HOMERdatabase) (Heinz et al. 2010) for enrichment
atDNMT.TKO-specific THSs,we identified theNRF1motif as being
the most enriched, consistent with the findings of Domcke et al.
(2015) (Supplemental Fig. S2J; Supplemental Table S5). Similar to
their results, sequence motifs recognized by the NFY complex,
ETS and basic Helix-Loop-Helix (bHLH) transcription factors
were also enriched in DNMT.TKO THSs. In vitro affinity measure-
ments and locus-specific ChIP evidence suggest that the binding of
these transcription factors to their cognate recognition sites is sen-
sitive to DNA methylation (Hu et al. 2017; Yin et al. 2017), sup-
porting the idea that accessibility gains occur in the absence of
DNA methylation due to unimpeded binding of these proteins.
We next examined the effects of HDAC inhibition on the
chromatin accessibility landscape of wild-type and DNMT.TKO
mES cells. Few loci displayed significant accessibility gains in
TSA- versus DMSO-treated cells, relative to the numbers identified
when comparing DNMT.TKO toWT. In fact, we observed that the
vast majority of regions display reduced accessibility in cells upon
HDAC inhibition, in both WT and DNMT.TKO cells (Fig. 2A;
Supplemental Fig. S2H). The effect was more pronounced in cells
depleted of DNA methylation, in which 38% of all THSs showed
a significant reduction in ATAC-seq signal when treated with
TSA. Congruently, THSs in TSA-treated cells are smaller, as seen
when aggregating the signal across all THSs or at individual sites
in the genome (Fig. 2B,C). We further noted that genome accessi-
bility changes at THSs were similar between TSA-treated WT and
DNMT.TKO cell lines (Spearman’s correlation coefficient = 0.649)
(Fig. 2D). In contrast, there was a considerable discrepancy in the
changes occurring with either DNA methylation loss or TSA treat-
ment (Spearman’s correlation coefficient = 0.187) (Fig. 2E).
Consequently, the main difference in the response to HDAC inhi-
bition in either the presence or absence of DNAmethylation is the
magnitude of the changes.
We then examined the relationship between TSA-induced
changes in H3 acetylation and genome accessibility (Supplemen-
tal Fig. S3A). THSs which lose or display no change after TSA treat-
ment had similar gains in H3 acetylation, whereas THSs which
gained accessibility demonstrated elevated acetylation (Supple-
mental Fig. S3A, bottompanel). Discordance between loss of acces-
sibility and H3 acetylation prompted us to examine the possibility
that the observed loss of accessibility might be an indirect effect
and subject to a different interpretation. Reduced signal at THS in-
tervals in TSA-treated samples indicates that DNA fragments orig-
inating from these regions are underrepresented as a fraction of the
entire ATAC-seq library, relative to their fraction in untreated sam-
ples. Concurrently, a larger proportion of fragments mapping to
the inaccessible compartment of the genome (i.e., the back-
ground) are sequenced. We envision two possible explanations
for this observed reduction of ATAC-seq signal at THS intervals.
The first possibility is that, upon TSA treatment, chromatin
accessibility is reduced at THSs, meaning that fewer reads would
be obtained from within these intervals. As a consequence of se-
quencing a fixed number of DNA fragments, we would thus ob-
serve a relative increase in accessibility signal from the genomic
compartment outside THSs (the “inaccessible” compartment).
According to this hypothesis, the additional reads sequenced
from the inaccessible compartment would be distributed evenly
throughout the remaining genomic space. The second possibility
is that TSA treatment results in elevated accessibility in genomic re-
gions outside of THSs. The relative reduction in the ATAC-seq sig-
nal at THSs then becomes a secondary consequence of elevated
accessibility outside THSs. This scenario would be supported if
wewere to identify an enrichment in accessibility at particular sub-
divisions of the inaccessible compartment.
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Figure 2. DNA methylation and HDAC activity have distinct contributions to the chromatin accessibility landscape. (A) Volcano plots representing the
false discovery rate (FDR) and fold change values obtained through pairwise differential analyses of ATAC-seq signal at 83,395 THSs. Regions with signifi-
cantly differential accessibility are shown in red on the scatterplots and their numbers are summarized in the form of pie charts (light blue = significant
decrease; red= significant increase). (B) Metaplot showing the average ATAC-seq signal from DMSO- or TSA-treated wild-type and DNMT.TKO cells in
4-kb regions surrounding the center of THSs (n=83,395). (C) Representative UCSC Genome Browser snapshot showing CpG methylation levels and
ATAC-seq read coverage. (D) Scatterplot comparing the fold change in ATAC-seq signal following TSA treatment in DNMT.TKO versus wild-type cells.
(E) Scatterplot comparing the fold change in ATAC-seq signal after loss of DNA methylation versus the change seen following TSA treatment in wild-
type cells at 83,395 THSs. In D and E, the dashed line has a slope of 1 and intercept of 0. Colors indicate density of points per graph area. SCC=
Spearman’s correlation coefficient. (F) Box plots summarizing the percentage of reads from each ATAC-seq library that map to intervals split into three
mutually exclusive categories. Two-tailed Student’s t-tests; (∗) P-value < 0.05, (∗∗) P-value < 0.01, (ns) nonsignificant (P-value > 0.05). (G) Box plots summa-
rizing the distribution of reads from each ATAC-seq library that map to intervals split into three mutually exclusive categories, relative to the distribution
expected by chance, that is, if non-THS reads were shuffled randomly within the genomic space outside of THSs. Values shown in F are divided by those in
Supplemental Figure S3B. (H) Distribution of ATAC-seq reads across different classes of repetitive elements as a percentage of the total library size. Data are
represented as mean+ SD. Two-tailed Student’s t-tests; (∗) P-value < 0.05, (∗∗) P-value < 0.01, nonsignificant differences are not indicated.
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To explore the above-mentioned interpretations, we calculat-
ed the fraction of reads in the ATAC-seq libraries that overlapped
with three categories of genomic regions: transposase hyperacces-
sible regions (THSs, 83,395 intervals covering 55Mb, 2.03% of the
mm10 genome); genomic intervals consisting of repetitive ele-
ments (RepMask intervals, excluding sequences that overlap
THSs, 1.19 Gb, 43.39% of mm10 genome); and the remaining ge-
nomic space (unannotated regions, 54.58%) (Fig. 2F). This analysis
shows that gains in accessibility in TSA-treated samples occur pref-
erentially at repetitive elements compared to unannotated regions
(Fig. 2F), supporting a contribution from the second scenario out-
lined above. The increase in coverage observed at repeats is larger
than that obtained if the same number of non-THS sequencing
reads are randomly shuffled into the combined “RepMask” and
unannotated genomic compartments (Fig. 2F; Supplemental Fig.
S3B,C). Furthermore, the distinct accessibility changes observed
at repeat regions are unlikely to be solely a consequence of differ-
ences in the induction of histone acetylation, as the H3ac levels
in both compartments are equivalent following HDAC inhibition
(Supplemental Fig. S3D). These results argue against the first pro-
posed mechanism being responsible for the reduction in ATAC-
seq signal at THSs in TSA-treated samples. Rather, our findings sug-
gest that genome-wide hyperacetylation following HDAC inhibi-
tion encourages gains in accessibility at repeat elements.
Although gains in accessibility occur preferentially at repetitive el-
ements in TSA-treated cells, any additional increase in accessibility
globally cannot be excluded using our experimental setup.
We next subdivided the repeat regions further by examining
the changes in accessibility occurring at various classes of repeti-
tive elements (Fig. 2H). We found that the fraction of reads map-
ping to LINE and LTR elements increased upon TSA treatment,
although this was significant in DNMT.TKO but not in WT cells.
Differential analysis of the ATAC-seq coverage between samples re-
vealed that there were significant increases in the number of
ATAC-seq reads mapping to 33 of the 132 LINE-1 (or L1) element
subfamilies in TSA- versus DMSO-treated wild-type cells (Supple-
mental Fig. S3E; Supplemental Table S3). In DNMT.TKO cells, sig-
nificant gains were detected for an additional five subfamilies
(Supplemental Fig. S3F). Themost significant gains in accessibility
in TSA-treated cells were observed at the youngest LINE-1 subfam-
ilies (Supplemental Fig. S3G), suggesting that the presence of in-
tact transcription factor binding sites may be important in
permitting accessibility. Among the LTR repeats, accessibility gains
in DNMT.TKO cells predominantly occurred at ERVK-type ele-
ments (Supplemental Fig. S3H). HDAC inhibition potentiated
these gains while also increasing accessibility at some ERVL and
ERVL-MalR-type repeats. Together, our ATAC-seq analysis indi-
cates that a subset of normally methylated loci increases in acces-
sibility in the absence of DNA methyltransferases, likely
representing novel transcription factor binding sites. A distinct ef-
fect was observed upon HDAC inhibition, where the resulting ge-
nome-wide hyperacetylation led to an increase in accessibility
outside of previously hyperaccessible sites (THSs), particularly at
a subset of LINE elements and LTR retrotransposons.
DNAmethylation and HDAC activity can modulate transcription
factor occupancy
NRF1 and NFY transcription factor motifs were enriched in THSs
that appeared in DNMT.TKO cells, whereas HDAC inhibition re-
sulted in the appearance of THSs containing DNA sequences
recognized by the AP-2 complex and TRP53 (Supplemental Figs.
S2J, S3I). Elevated chromatin accessibilitymay be a result of abnor-
mal TF binding (Domcke et al. 2015; Maurano et al. 2015); howev-
er, it is not known whether our chromatin perturbations cause
more widespread TF binding without inducing transposase hyper-
sensitivity. Thus, we decided to directly measure how DNA meth-
ylation and histone acetylation affect the genomic distribution of
selected transcription factors. We performed ChIP-seq in WT and
DNMT.TKO mESCs in the presence or absence of TSA, to map
the genome-wide occupancy of five transcription factors
(GABPA, MAX, NRF1, SP1, and YY1) that possess distinct DNA-
binding domains and are known to bind cognate sequences con-
taining CpG dinucleotides (Fig. 3A).
We identified 4735, 19,236, 3102, 6666, and 6055 regions as
being reproducibly occupied byGABPA,MAX,NRF1, SP1, and YY1
in at least one experimental condition, respectively (Supplemental
Table S2). Biological replicates clustered together (Supplemental
Fig. S4A) and the DNA motifs known to be bound by these tran-
scription factors were the most highly enriched within the identi-
fied ChIP-seq peaks relative to the entire collection ofmotifs in the
HOMER database, providing assurance of the specificity of these
ChIP assays (Supplemental Fig. S4B). Moreover GABPA, NRF1,
SP1, and YY1 protein abundance is not substantially affected in
our examined conditions (Supplemental Fig. S4C). A small reduc-
tion of SP1 andNRF1 is observed after treatment with TSA; howev-
er, this would not be able to explain the predominant gains in
occupancy of these TFs (Fig. 3B).
For all five transcription factors, loss of DNA methylation or
HDAC inhibition resulted in increased transcription factor
occupancy (Fig. 3B). However, the relative impact of these two al-
terations varied depending on the individual protein. In accor-
dance with our ATAC-seq analysis (Supplemental Fig. S2J), NRF1
gained novel binding sites in DNMT.TKO compared to wild-type
cells (Fig. 3B). As these regions are methylated in wild-type cells
(Fig. 4A), this suggests that DNA methylation restricts NRF1 bind-
ing at certain genomic loci, in line with previous reports (Kumari
and Usdin 2001; Domcke et al. 2015). On the other hand, HDAC
inhibition did not have a substantial effect on the genome-wide
occupancy of NRF1, with relatively few sites showing differential
binding upon TSA treatment in wild-type or DNMT.TKO cells
(Fig. 3B; Supplemental Fig. S4D).
A small number of differential binding sites were identified
for SP1 when comparing TSA-treated or DNMT.TKO cells to wild-
type cells, suggesting that this transcription factor’s occupancy is
mostly unaltered by global loss of DNA methylation or genome-
wide hyperacetylation alone (Fig. 3B).
Occupancy of GABPA, MAX, and YY1 can be modulated by
both DNA methylation and histone acetylation (Fig. 3B). At
some binding sites, either DNA methylation or HDAC activity
alone seem to be sufficient to restrict binding of these factors
(Fig. 3C; Supplemental Fig. S5A,D vs. Fig. 3D; Supplemental Fig.
S5B,E), whereas at other loci the combination of both appears to
be responsible for impeding occupancy (Fig. 3E; Supplemental
Fig. S5C,F). Binding sites newly acquired in DNMT.TKO cells pre-
dominantly harbor the respective TF binding motifs, and these
are methylated in WT cells (Fig. 4A,B). Furthermore, treatment
with TSA resulted in elevated histone acetylation in the novel
peaks, reinforcing the model that occupancy gains are a direct re-
sult of chromatin perturbations (Supplemental Fig. S4E).
Although all five transcription factors predominantly occupy
gene promoter regions, the majority of ChIP-seq peaks that
showed significant increases in occupancy upon DNA methyla-
tion loss or HDAC inhibition were situated at promoter distal
Chromatin impact on function of TFs
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Figure 3. DNAmethylation and HDAC activity canmodulate transcription factor occupancy. (A) For each transcription factor, the position weight matrix
(PWM) of its known motif and its DNA-binding domain (DBD) type are shown. (B) Pairwise comparisons of normalized GABPA, MAX, NRF1, SP1, or YY1
ChIP-seq signal for all identified occupancy peaks. Regions with significantly differential occupancy are colored on the scatterplots, and their numbers are
summarized in the form of pie charts (light blue = significant decrease; red= significant increase). ChIP-seq signal from three biological replicate samples
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genomic sites (Supplemental Fig. S6A). The exception to this is
GABPA, for which TSA treatment resulted in occupancy of loci
proximal to TSSs. This is likely related to the observation that
TSA treatment relocates some of GABPA exclusively to nonmethy-
lated loci (Fig. 4A), often found within CpG islands near TSSs.
We further examined whether novel intergenic ChIP-seq
peaks overlapped with transposable elements (LTRs, LINEs, and
SINEs). Most strikingly, over half of DNMT.TKO or TSA-specific
YY1 ChIP-seq peaks overlapped with transposable elements (Fig.
4C). Particularly, 652 out of 1067 YY1 binding sites acquired in
the absence of both DNA methylation and HDAC activity locate
to LINE retrotransposons. Multiple LINE subfamilies exist in the
mouse genome that are classified by the sequence of the mono-
meric units that are tandemly repeated to make up their 5′ UTR
promoters (Goodier et al. 2001; Sookdeo et al. 2013; Zhou and
Smith 2019). Only full-length members of the youngest L1 sub-
families, containing A-, TF-, or GF-type promoters are capable of
retrotransposition, with the TF subtype being the most active in
somatic cells and the germline (Akagi et al. 2008; Richardson
et al. 2017; Schauer et al. 2018). Of the LINE-1 elements bound
by YY1 in TKO.TSA samples, 537 belonged to the L1Md_T subfam-
ily (82%) and 54 to the L1Md_Gf type (8.3%) (Supplemental Fig.
S6B). Both of these L1 subtypes are known to have YY1 binding
motifs in their promoter sequences that are important for retro-
transposition (DeBerardinis and Kazazian 1999; Goodier et al.
2001; Athanikar et al. 2004; Sanchez-Luque et al. 2019). Indeed,
525 of the L1Md_T and 25 of the L1Md_Gf elements that showed
increased YY1 occupancy in the absence of DNAmethylation and
HDAC activity were full-length members of their families (>5000
bp and >4000 bp, respectively) and most contained at least one
YY1-containing monomeric units within their 5′UTR regions
(Supplemental Figs. S6C, S5E). LINE elements and particularly
the L1Md_T and Gf subtypes also showed significant gains in ac-
cessibility in TSA-treated cells (Fig. 2G; Supplemental Table S3),
A B
C
Figure 4. Characteristics of transcription factor (TF) binding sites. (A) Distribution of CpG methylation levels within the TF motifs that underlie ChIP-seq
peaks. For each TF, we isolated all sequences that were located within peak regions that matched the relevant position weight matrix and determined the
methylation status of the CpG nucleotides. CpG sites are grouped according to their differential occupancy. Black dots indicate themedian. (B) Distribution
of maximum log-odds scores found at different subsets of ChIP-seq peaks. Within each interval of the GABPA, MAX, NRF1, SP1, and YY1 peak-sets, the
sequence most similar to the respective PWM was identified and its log-odds score, indicative of the deviation from the consensus sequence, was plotted.
Black dots indicate the median. The dashed lines indicate the log-odds score threshold above which a sequence is said to match the PWM. (C) Fraction of
ChIP-seq peaks that overlap an annotated transposable element. ChIP-seq peaks are classified based on their differential occupancy.
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consistent with a model in which tran-
scription factor binding in the absence
of HDAC activity and DNA methylation
is contributing to chromatin opening.
A high fraction of the YY1 binding
sites acquired in DNMT.TKO cells over-
lapped with LTR retrotransposons, of
which 34/42 were ERVK-type elements
(Fig. 4C). YY1 occupancy increases only
modestly in the absence of DNAmethyl-
ation or following HDAC inhibition
(Supplemental Fig. S6D, left panel; Sup-
plemental Fig. S5F). This differs from
YY1 occupancy at LINE elements, which
occurs after HDAC inhibition but not as a
consequence of DNA methylation loss
alone (Supplemental Fig. S6D, right pan-
el). In both cases, YY1 occupancy is high-
est after HDAC inhibition in DNA
methylation-deficient cells (Supplemen-
tal Fig. S6D).
Altogether, our analysis of ChIP-seq
data indicates that both DNA methyla-
tion and HDAC activity play distinct
roles in limiting occupancy of each of
the examined TFs to a fraction of their
binding sites. Furthermore, we did not
detect a significant loss in transcription
factor occupancy at pre-existing peaks
following HDAC inhibition, whereas
novel binding events were observed
throughout the genome. These findings
support our previous interpretation of
the ATAC-seq data: that chromatin acces-
sibility increases preferentially outside of
established THSs and particularly at LINE
and LTR retrotransposons.
Transcription factor occupancy can
promote chromatin accessibility in
mESCs with perturbed DNA
methylation or HDAC activity
We next asked whether the gains in tran-
scription factor occupancy in unmethy-
lated or hyperacetylated cells were
directly associated with increased chro-
matin accessibility. For each transcrip-
tion factor, we evaluated the changes in
ATAC-seq signal at intervals that were oc-
cupied in one of our conditions. General-
ly, increased GABPA, MAX, NRF1, and
YY1 binding in DNMT.TKO cells was as-
sociated with significant gains in accessi-
bility (Fig. 5A, top row). Novel binding
events mostly occurred at sites that were
previously inaccessible (Fig. 5B, top),
and a few coincided with an increase in
ATAC-seq signal that was sufficient to be detected as a THS. Elevat-
ed transcription factor occupancy following HDAC treatment was
also associated with significant gains in accessibility, although for
GABPA this was only found to be the case after TSA treatment in
DNMT.TKO but not WT cells (Fig. 5A, bottom two rows). Whereas
HDAC inhibition led to increased occupancy of MAX, NRF1, and
YY1 at predominantly inaccessible loci (i.e., that do not overlap
any THS), the majority of sites to which GABPA and SP1 were
A
B
Figure 5. Transcription factor occupancy can promote chromatin accessibility in mESCs with per-
turbed DNAmethylation or HDAC activity. (A) Quantitation of ATAC-seq fold change at transcription fac-
tor ChIP-seq peaks grouped according to their differential occupancy. Black dots indicate the median
ATAC-seq fold change. One-tailed Mann–Whitney U tests; (∗) P-value <0.05, (∗∗) P-value <0.01, (∗∗∗)
P-value < 0.001, (∗∗∗∗) P-value < 10−10, (ns) nonsignificant (P-value > 0.05). (B) Percentage of ChIP-seq
peaks that overlap with a Tn5 hypersensitive site (THS). In the top panel, a “pre-existing” THS refers to
an ATAC-seq peak identified in samples generated from untreated WT cells, whereas a novel THS is iden-
tified in DNMT.TKO but not WT cells. In the bottom panel, a “pre-existing” THS was identified in samples
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relocated were previously accessible (Fig. 5B, bottom). This finding
is in agreement with our previous observations that all GAPBA and
half of SP1 TSA-specific binding sites occur at promoter regions
with low levels of DNA methylation (Fig. 4A; Supplemental Fig.
S6A). Novel TF binding events that appear followingHDAC inhibi-
tion are less commonly associated with increased accessibility
when compared to DNMT.TKO-specific binding events, whereas
the amplitude of change is also smaller (Fig. 5A). Although this ob-
servation might reflect a different capacity of HDAC inhibition to
induce THSs, compared to DNA demethylation, we cannot ex-
clude the possibility that the lower signal is a consequence of the
depletion in ATAC-seq reads from THSs after treatment with TSA.
DNAmethylation loss and HDAC inhibition affect the expression
of specific genes and retrotransposons
Having established that bothDNAmethylation loss andHDAC in-
activation can lead to changes in chromatin accessibility and tran-
scription factor occupancy, we next examined the consequences
for gene expression. To this aim, we performed RNA-seq using
wild-type and DNMT.TKO cells following treatment with TSA or
DMSO. Loss of DNAmethylation was associated with the differen-
tial expression of hundreds of genes (5.8% of total) whereas HDAC
inhibitionhad amore profound effect, with 20%and 27%of genes
being significantly deregulated in TSA-treated wild-type and
DNMT.TKO cells, respectively (Supplemental Fig. S7A; Supple-
mental Table S4).
We first explored the relationship between changes in chro-
matin accessibility and gene expression. We assigned each THS
to its nearest transcription start site and examined the gene expres-
sion differences. We observed weak correlations between changes
in chromatin accessibility and expression of the neighboring gene
(Spearman’s correlation coefficients for TKO.DMSO vs.
WT.DMSO, WT.TSA vs. WT.DMSO, or TKO.TSA vs. TKO.DMSO
are 0.15, 0.11, and 0.10, respectively) (Fig. 6A), indicating that
most chromatin accessibility alterations are not associated with
transcriptional changes at the closest gene. Nevertheless, more dif-
ferentially accessible THSs showmatching changes in neighboring
gene expression than expected by chance (Fig. 6A). Many of the
differential THSs are promoter distal and may represent loci with
no regulatory function or that regulate transcriptional elements
other than the closest gene. Limiting the list of THSs to those
that are promoter proximal strengthens the correlation with
gene expression when comparing WT and DNMT.TKO cells but
not TSA and control treatments (Supplemental Fig. S7B).
At 28 promoters, significant changes in accessibility did asso-
ciate with significantly increased gene expression in DNMT.TKO
cells (Fig. 6B,C; Supplemental Fig. S7B). These 28 genes are en-
riched for genes whose expression is normally restricted to testes
(Supplemental Table S5), fitting with a known role for DNAmeth-
ylation in controlling the expression of germ cell-specific genes
(De Smet et al. 1999; Maatouk et al. 2006; Fouse et al. 2008;
Borgel et al. 2010; Auclair et al. 2014). In conclusion, DNA meth-
ylation can restrict gene expression bymaintaining an inaccessible
chromatin state; however, the majority of gained THSs both in de-
methylated or hyperacetylated genomes are unable to affect the
mRNA abundance of the nearest genes.
Considering our observations that certain subtypes of LINE-1
and LTR retrotransposonswere selectively accessible and bound by
transcription factors following DNAmethylation loss or HDAC in-
hibition,we turned our attention to transcription originating from
these repetitive elements. In the case of LINE-1 and ERVL-type LTR
repeats, we noticed that increases in accessibility that are observed
following HDAC inhibition but not after loss of DNAmethylation
were associated with significantly elevated levels of RNA originat-
ing from various subtypes (Fig. 6D; Supplemental Fig. S8A,C;
Supplemental Table S3). These included the young L1Md_T, Gf,
and A subtypes for which there was also enrichment for YY1 or
GABPA ChIP-seq reads (Fig. 6D), as well as MT2-Mm and
MERVL-int ERVL elements. In the case of ERVK-type repeats, loss
of DNA methylation rather than HDAC inhibition accounts for
themost pronounced increases in accessibility, although this is re-
stricted to a subset of repeat types, including IAP elements
(Supplemental Fig. S8B,C). However, the expression from ERVK-
type elements is most strongly induced when both DNAmethyla-
tion andHDAC activity are abolished (comparing TKO.TSA cells to
WT.DMSO). This observation agrees with previous reports docu-
menting a synergistic activation of ERVK-type repeats in response
to a combined removal of DNA methylation and HDAC activity
(Cameron et al. 1999; Coffee et al. 1999; Walter et al. 2016;
Brocks et al. 2017).
In summary, elevated transcription factor binding and ge-
nome accessibility in the absence of DNA methylation or after
HDAC inhibition promote activation of a small subset of genes,
while up-regulating expression of the youngest and potentially
mobile LINE-1 and LTR repeats.
Discussion
In this study,we demonstrate that transcription factors havediffer-
ent abilities to sense chromatin modifications. Even when exam-
ining a small number of TFs, we were able to capture distinct
scenarios in which TF occupancy is affected by neither DNAmod-
ifications nor histone acetylation (SP1), exclusively by DNAmeth-
ylation (NRF1), or by both (GABPA, MAX, SP1, and YY1) (Fig. 7).
The total number of new binding events varies between tran-
scription factors and does not correlate with the number of all po-
tential binding sites (i.e., sequences that match its cognate motif
perfectly). For example, in DNA methylation-deficient cells,
NRF1 gains occupancy at 216 loci (increase by 0.6%of all potential
binding sites), whereas MAX gains occupancy at 752 (0.26%), YY1
– 74 (0.02%), and GABPA – 83 (0.02%) loci. Changes of a similar
magnitudehave been reported independently for another two pro-
teins, MYCN and CTCF, in DNMT.TKO mES cells (Stadler et al.
2011; Yin et al. 2017). Comprehensive in vitro experiments
indicate that there are >100 TFs whose affinity to DNA is dimin-
ished by cytosine methylation (Hu et al. 2013; Yin et al. 2017).
Therefore, although the contribution of DNA methylation in re-
stricting the occupancy of individual transcription factors appears
limited, the cumulative effect of DNA methylation loss on the
gene regulatory network is likely to be more substantial.
Unlike the effect of DNAmethylation depletion, HDAC inhi-
bition did not result in the emergence ofmany discrete Tn5 hyper-
sensitive loci. Rather, increased chromatin accessibility was
observed throughout the genome and particularly at a subset of
abundant LINE and LTR transposable elements that led to a signif-
icant skew in the composition of ATAC-seq libraries. Despite ge-
nome-wide hyperacetylation, aberrant binding of the examined
transcription factors occurred at a scale similar to that seen follow-
ing the loss of DNAmethylation. Perturbations to the DNAmeth-
ylationmachinery or HDAC activity had distinct impacts onMAX,
GABPA, and YY1 localization both in terms of the number of aber-
rantly occupied loci as well as the genomic location of these alter-
ations, indicating that DNA methylation does not depend on
Chromatin impact on function of TFs
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Figure 6. DNA methylation loss and HDAC inhibition affect the expression of specific genes and retrotransposons. (A) Changes in accessibility at every
THS region were compared to changes in expression at their closest gene. The analysis was performed on 60052 THS:gene pairs involving 15,298 genes.
The numbers of THSs associatedwith significant changes in both accessibility and gene expression are indicated in red in each quadrant. In parentheses are
indicated the expected numbers of sites showing both significant changes in accessibility and gene expression based on the total number of significant
differential events. SCC= Spearman’s correlation coefficient. (B,C) Representative UCSC Genome Browser snapshots showing CpG methylation levels,
ChIP-seq, ATAC-seq, and strand-specific RNA-seq read coverage. The position of genes and that of sequences that match the TF motifs are shown.
(D) For each LINE-1 subtype (N=132), we plotted the fold change in ATAC-seq, ChIP-seq, or RNA-seq signal along with scores relating to their sequence
conservation (purple) or the presence of selected TF bindingmotifs (green). LINE-1 subtypes were sorted based on ATAC-seq adjusted P-values when com-
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HDAC activity to restrict TF occupancy in mouse ES cells. One of
the models that is recurrently proposed to explain the transcrip-
tional silencing activity of DNAmethylation suggests thatmethyl-
ated CpG sequences recruit MBD-domain proteins whose
associated HDAC enzymes promote transcriptional repression
(Eden et al. 1998; Nan et al. 1998; Kokura et al. 2001; Lyst et al.
2013). Except for a small number of cases, the effect of HDAC in-
hibition on chromatin accessibility, TF occupancy and gene ex-
pression does not recapitulate that of DNA methylation loss, in
line with similar observations in mESCs (Brunmeir et al. 2010;
Reichmann et al. 2012) and other cell lines (Lorincz et al. 2000;
Brocks et al. 2017), arguing that, at large, DNA methylation func-
tions independently of HDACs. A more direct role for cytosine
methylation in lowering the affinity between transcription factors
and their cognate DNA sequences is, however, consistent with our
data, as well as being supported by various biochemical and struc-
tural experiments (Prendergast and Ziff 1991; Spruijt et al. 2013;
Dantas Machado et al. 2015; Stephens and Poon 2016; Yin et al.
2017).
On the other hand, the manner by which histone deacetyla-
tion hinders transcription factor binding is unclear and remains to
be elucidated. One potentialmodelmight be that TFs are unable to
outcompete compact chromatin, which hypoacetylated nucleo-
somes are known to produce in vitro (Hong et al. 1993; Lee et al.
1993; Anderson et al. 2001; Shogren-Knaak et al. 2006; Wang
and Hayes 2008).
Although there are only a few genomic loci for which HDAC
inhibition or DNAmethylation loss are directly responsible for al-
tered TF binding and transcriptional activity, these elements are of
biological and potentially clinical significance. LINEs and ERVLs,
for example, are reported to be essential for early embryonic devel-
opment following fertilization (Jachowicz et al. 2017; Percharde
et al. 2018; Kruse et al. 2019), a period during which histone acet-
ylation is elevated and DNA methylation is low (Macfarlan et al.
2012; Ishiuchi et al. 2015; Eckersley-Maslin et al. 2016).
Moreover, LINE mobility is observed in ES cells and is important
in genomic diversification (Akagi et al. 2008; MacLennan et al.
2017; Richardson et al. 2017). In human somatic tissues, aberrant
L1 retrotransposition has been linked to cancer (Carreira et al.
2014; Tubio et al. 2014; Scott and Devine 2017; Schauer et al.
2018). Inhibitors of HDAC and DNMT enzymes are being used
for the treatment of acute myelogenous leukemia, and their use
against solid tumors is being considered in combination with im-
mune checkpoint inhibitors (Navada et al. 2014; West and
Johnstone 2014; Daskalakis et al. 2018).
In summary, we demonstrate that deacetylation of histones
and DNA methylation are two important activities in chromatin,
which collaborate to limit TF occupancy and contribute to silenc-
ing of retrotransposon expression.
Methods
Cell culture and treatment
Dnmt1−/−, Dnmt3a−/−, and Dnmt3b−/− TKO (DNMT.TKO,
[Tsumura et al. 2006]) and their parental wild-type J1 male mouse
embryonic stem cells (strain 129S4/SvJae) were grown on 0.1% gel-
atin-coated dishes in DMEM (Lonza) complemented with 10% (v/
v) fetal bovine serum (Biosera, FB-1001G/500, lot #11484), 2 mM
L-glutamine (Thermo Fisher Scientific), 1% (v/v) nonessential ami-
no acids (Thermo Fisher Scientific), 1% (v/v) penicillin-streptomy-
cin (Thermo Fisher Scientific), 10 ng/mL leukaemia inhibitory
factor (LIF, produced in-house following a protocol by Tomala
et al. 2010), and 0.1 mM beta-mercaptoethanol (Sigma-Aldrich).
Chicken DF-1 (Doug Foster strain 1) fibroblast cells were grown
in DMEM (Lonza) supplemented with 10% (v/v) fetal bovine se-
rum (Biosera, FB-1001/500, lot #014BS386), 1% (v/v) penicillin-
streptomycin (Thermo Fisher Scientific), 2 mM L-glutamine
(Thermo Fisher Scientific), and 0.15% sodium bicarbonate
(Thermo Fisher Scientific). All cells were incubated in a humidified
incubator set at 37°C and 5% atmospheric CO2.
HDAC inhibition inmESCswas achieved using Trichostatin A
(TSA, Sigma-Aldrich, T1952). Cells were seeded 4–6 h prior to treat-
ment; once attached, their growth mediumwas replaced with me-
dium containing 5 ng/µL TSA. TSA-containing media was
refreshed after 24 h, and cells were harvested for downstream ap-
plications after 36 h. Control DMSO-treated cells were seeded
and treated in a similar manner; however, medium contained
0.0033% DMSO.
Calibrated native chromatin immunoprecipitation with
exogenous spike-in
ChickenDF-1 andmouse ES cells were harvested by trypsinization.
For each experimental condition, 5 ×106 chicken DF-1 cells were
added to 5×107 mESCs. Cell mixtures were pelleted and resus-
pended in 1 ml ice-cold RSB Buffer (10 mM NaCl, 10 mM Tris
[pH 8.0], 3 mM MgCl2). Chromatin was fragmented by adding
200 units of Micrococcal Nuclease (MNase, Fermentas) and incu-
bating at 37°C for 5min. The reaction was stopped by the addition
of 8 µL of 0.5 M EDTA and spun at 2348g for 5 min at 4°C. The su-
pernatant containing soluble nucleosomes was collected (S1 frac-
tion). Nucleosomes in the remaining insoluble fraction were
extracted by rotating in 300 µL Nucleosome Release Buffer (10
mM Tris [pH 7.5], 10 mM NaCl, 0.2 mM EDTA, with 1×
cOmplete EDTA-free Protease Inhibitor Cocktail [Roche] and 10
mM sodium butyrate) for 1 h at 4°C followed by passing through
a 25G needle five times. The supernatant was collected as de-
scribed above and pooled with the S1 chromatin fraction. DNA
fragment size was checked by agarose gel electrophoresis, indicat-
ing that themajority of the fragments aremononucleosomal DNA
(150–200 bp) with a small fraction of di- and tri nucleosomal.
Immunoprecipitations were set up with 100 µL solubilized
chromatin (roughly equivalent to 4×106 cells) and 3 µg of an anti-
acetylated histone H3 antibody (Millipore-Sigma 06-599) in a total
Figure 7. Summary model illustrating impact of DNA methylation and
HDAC inhibition on transcription factor occupancy.
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of 1 mL Native ChIP Incubation Buffer (10 mM Tris [pH 7.5], 70
mM NaCl, 2 mM MgCl2, 2 mM EDTA, and 0.1% Triton X-100,
1× cOmplete EDTA-free Protease Inhibitor Cocktail, and 10 mM
sodium butyrate) and rotated overnight at 4°C. Immune complex-
es were captured using 20 µL Protein A agarose beads (Roche, pre-
viously saturated with 1 mg/mL BSA and 1 mg/mL yeast tRNA) for
1 h at 4°Cwith rotation,washed four timeswithNativeChIPWash
Buffer (20 mM Tris [pH 7.5], 2 mM EDTA, 125 mM NaCl, 0.1%
Triton X-100) and once in TE buffer (10 mM Tris HCl [pH 8.0], 1
mM EDTA), and subsequently eluted in 100 µL elution buffer
(1% SDS, 0.1 M NaHCO3) by vigorous shaking for 30 min at
room temperature. DNA was purified using the ZymoResearch
ChIP DNA clean and concentrator kit (Zymo Research) following
themanufacturer’s instructions. For input samples, DNAwas puri-
fied from100 µL of solubilized chromatin using the sameDNApu-
rification procedure.
Material was quantified using Qubit (Invitrogen) and the size
profile analyzed on the 2200 or 4200 TapeStation (Agilent, dsDNA
HS Assay). Automated library preparation was performed on 5 ng
input material using the Apollo prep system (Wafergen, PrepX
ILMN 32i, 96 sample kit) and standard Illumina multiplexing
adapters following the manufacturer’s protocol up to pre-PCR am-
plification. Libraries were PCR-amplified (18 cycles) on a Tetrad
(Bio-Rad) using the NEBNext High-Fidelity 2X PCR Master Mix
(NEB) and in-house single indexing primers (Lamble et al. 2013).
Equivalent amounts of individual libraries were pooled. Paired-
end sequencing was performed using a HiSeq 4000 75-bp platform
(Illumina, HiSeq 3000/4000 PE Cluster kit and 150 cycle SBS kit),
generating a raw read count of >30 million reads per sample (Sup-
plemental Table S1). Data analysis is provided in Supplemental
Material.
ATAC-seq with exogenous spike-ins
Assay for Transposase Accessible Chromatin (ATAC)-seq experi-
ments were carried out by adapting the protocol published by
Buenrostro et al. (2013). Details of the sample preparation and
data analysis are provided in Supplemental Material.
Chromatin immunoprecipitation for transcription factors
We describe the protocol for chromatin immunoprecipitation in
detail in the Supplemental Material. In brief, mouse ES cells were
crosslinked in 1% methanol-free formaldehyde (Thermo Fisher
Scientific) alone or sequentially with 2 mM disuccinimidyl
glutarate (DSG) first, then 1% formaldehyde (YY1 only). Immuno-
precipitation was carried out on sonicated chromatin using anti-
bodies listed in Supplemental Table S6. Following stringent
washing, reverse crosslinking and DNA purification, libraries
were prepared and sequenced using the same procedure as de-
scribed for the native chromatin immunoprecipitation with exog-
enous spike-in experiments.
RNA-seq sample preparation and sequencing
Total RNA was isolated from mES cells using the TRI Reagent
(Sigma-Aldrich) following the protocol provided by the manufac-
turer. Contaminating genomic DNA was removed by incubating
10 µg RNA with 10 U DNase I (Thermo Fisher Scientific) in
Reaction Buffer for 30 min at 37°C. The reaction was stopped by
adding 10 µL of 50mMEDTA after which RNAwas extracted using
a phenol-choloroform purification and ethanol precipitation.
Material was quantified using RiboGreen (Invitrogen) on the
FLUOstar OPTIMA plate reader (BMG Labtech) and the size profile
and integrity analyzed on the 2200 (Agilent, RNA ScreenTape).
Input material was normalized to 1 µg prior to library preparation.
Total RNAwas depleted of ribosomal RNA using a Ribo-Zero rRNA
Removal kit (Epicentre/Illumina, Human/Mouse/Rat), and library
preparation was completed using the NEBNext Ultra Directional
RNA Library Prep kit for Illumina (New England Biolabs), both fol-
lowing the manufacturer’s instructions. Libraries were amplified
for 12 cycles. Equivalent amounts of individual libraries were
pooled together. Paired-end sequencing was performed using a
HiSeq 2000 51-bp platform (v3 SBS chemistry), generating a raw
read count of >40 million reads per sample (Supplemental Table
S1). Data analysis is provided in Supplemental Material.
Analysis of publicly available WGBS data
Whole-genome bisulfite sequencing data from E14 mouse ESCs
(GSM1027571, Habibi et al., 2013) was analyzed using Bismark
(v 0.12.5). Only cytosines with a read coverage of five or more
were taken into account in this study.
Data access
ChIP-seq, ATAC-seq, and RNA-seq sequencing data generated in
this study have been submitted to the NCBI Gene Expression
Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) under acces-
sion number GSE131366.
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